Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Avita Medical Inc. (RCEL) had Revenue of $18.51M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$18.51M
Net Income	$-13.86M
Cost of Goods Sold	$2.83M
Gross Profit	$15.68M
Operating Expenses	$32.37M
Operating Income	$-13.85M
Non-Operating Income/Expense	--
Pre-Tax Income	$-13.85M
Normalized Pre-Tax Income	$-13.85M
Income after Taxes	$-13.86M
Income from Continuous Operations	$-13.86M
Consolidated Net Income/Loss	$-13.86M
Normalized Income after Taxes	$-13.86M
EBIT	$-12.62M
EBITDA	$-12.10M
Weighted-Average Shares Outstanding (Basic)	1.31M
Weighted-Average Shares Outstanding (Diluted)	1.31M
Earnings per Share (EPS) (Basic)	$-10.60
Earnings per Share (EPS) (Diluted)	$-10.60
Balance Sheet Financials
Current Assets	$47.97M
Property, Plant, and Equipment	$9.89M
Long-Term Assets	$21.59M
Total Assets	$69.56M
Current Liabilities	$22.96M
Long-Term Debt	$41.46M
Long-Term Liabilities	$51.17M
Total Liabilities	$74.13M
Common Equity	$-4.57M
Tangible Shareholders Equity	$-10.02M
Shareholders Equity	$-4.57M
Common Shares Outstanding	1.32M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-10.31M
Cash Flow from Investing Activities	$10.77M
Cash Flow from Financial Activities	$0.36M
Beginning Cash	$14.05M
End Cash	$14.87M
Increase/Decrease in Cash	$0.82M
Stock-Based Compensation	$2.69M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.09
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.12
Debt to Equity Ratio	-9.07
Gross Margin	84.70%
Operating Margin	-74.81%
EBIT Margin	-68.15%
EBITDA Margin	--
Pre-Tax Profit Margin	-74.81%
Profit Margin	-74.86%
Free Cash Flow	$-10.53M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.27
Inventory Turnover	0.34
Receiveable Turnover	1.54
Days Sales in Receivables	58.55
Return on Equity	303.19%
Return on Tangible Equity	138.34%
Return on Assets	-19.93%
Return on Investments	-37.57%
Book Value Per Share	$-3.46
Free Cash Flow per Share	$-8.02
Operating Cash Flow per Share	$-7.85

Data from Zacks Investment Research, Inc.